OAC
ABOS icon

OMERS Administration Corp’s Acumen Pharmaceuticals ABOS Stock Holding History

OMERS Administration Corp’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,600
Closed -$67.5K – 907
2026
Q1 		$67.5K Buy
28,600
+6,146
+27% +$15.7K ﹤0.01% 1048
2025
Q4 		$47.4K Buy
+22,454
New +$44.5K ﹤0.01% 998
2024
Q2 		– Sell
-23,800
Closed -$96.4K – 1030
2024
Q1 		$96.4K Buy
+23,800
New +$89.7K ﹤0.01% 324

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

OMERS Administration Corp's ABOS Position: Q2 2026 in Review

OMERS Administration Corp sold out of Acumen Pharmaceuticals (ABOS) in Q2 2026, closing a stake of 28,600 shares — an estimated $67.5K sold.

OMERS Administration Corp first reported a position in ABOS in Q1 2024 and held it in 3 quarters. The position peaked at $96.4K in Q1 2024. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • OMERS Administration Corp reported no remaining Acumen Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 28,600 Acumen Pharmaceuticals shares in Q2 2026, an estimated $67.5K.
  • OMERS Administration Corp first reported a position in Acumen Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • OMERS Administration Corp's Acumen Pharmaceuticals position peaked at $96.4K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.